VISTAGEN THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.375 USD | -2.34% |
|
-2.44% | -14.59% |
Chart calendar Vistagen Therapeutics, Inc.
373e8f360743.K3EuYRTualfwscE6Tf7R2y4gTukk3NmMI1mW0qmx9Vw.cSJkOUzaCBqx7rYMF4-2vWp6ArwQ5IrYUin96-_UzAVhCVgAWqEEBITemA~a941a10a745d037b94f0c76f317affbb
Upcoming events on Vistagen Therapeutics, Inc.
Past events on Vistagen Therapeutics, Inc.
| 13/04/2024 20:45 | Anxiety and Depression Association of America Conference - Poster No: S256 |
| 13/04/2024 20:45 | Anxiety and Depression Association of America Conference - Poster No: S125 |
| 20/03/2024 16:00 | Stifel CNS Day |
| 06/03/2024 15:30 | TD Cowen Health Care Conference |
| 13/02/2024 22:00 | Q3 2024 Earnings Call |
| 13/02/2024 21:20 | Q3 2024 Earnings Release |
| 14/11/2023 18:15 | Stifel Healthcare Conference |
| 10/11/2023 17:00 | CNS Summit |
| 09/11/2023 | Neuroscience Education Institute Congress - Poster No: 109 |
| 09/11/2023 | Neuroscience Education Institute Congress - Poster No: 89 |
| 09/11/2023 | Neuroscience Education Institute Congress - Poster No: 47 |
| 09/11/2023 22:00 | Q2 2024 Earnings Call |
| 09/11/2023 21:30 | Q2 2024 Earnings Release |
| 12/10/2023 20:00 | Jefferies Inaugural Biotech CNS/Neuro Summit - Fireside Chat |
| 03/10/2023 18:30 | LD Micro Main Conference |
| 24/09/2023 | Annual General Meeting |
| 10/08/2023 21:30 | Q1 2024 Earnings Call |
| 10/08/2023 21:21 | Q1 2024 Earnings Release |
| 28/06/2023 21:30 | Q4 2023 Earnings Call |
| 28/06/2023 21:25 | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 1,09 0,88 24.19% | 1,11 1,32 -16.28% | -0,23 -0,40 43.6% | 1,07 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -24,6 -25,1 2.22% | -20,8 -21,7 4.01% | -17,9 -18,6 3.69% | -47,8 -43,2 -10.49% | -59,3 -57,1 -3.84% | -32,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -24,6 -25,2 2.3% | -20,8 -21,6 3.99% | -17,9 -18,5 3.33% | -47,8 -43,2 -10.61% | -59,2 -57,1 -3.82% | -30,1 |
|
Net income Million USD | Released Forecast Spread | -25,7 -26,0 1.11% | -22,0 -22,7 3.08% | -42,3 -19,5 -116.91% | -48,7 -44,0 -10.75% | -59,2 -57,1 -3.83% | -30,1 |
|
EPS USD | Released Forecast Spread | -27,0 -27,3 1.1% | -15,0 -14,9 -1.01% | -14,7 -6,53 -125.29% | -7,50 -6,53 -14.94% | -8,51 -8,40 -1.31% | -1,60 |
| Announcement Date | 25/06/19 | 29/06/20 | 29/06/21 | 23/06/22 | 28/06/23 | - |
Quarterly results
| Fiscal Period | Maart | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,36 0,25 40.91% | 0,04 0,25 -84.68% | 0,31 0,24 29.95% | -0,89 0,21 -531.79% | 0,18 0,31 -42.06% | 0,18 0,00 - | 0,18 0,00 - | 0,28 0,00 - | 0,41 0,54 -24.44% | 0,20 | 0,40 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,5 -13,8 23.4% | -16,7 -12,2 -37.35% | -19,8 -16,0 -23.88% | -17,5 -13,6 -28.81% | -9,77 -14,2 31.44% | -12,2 -10,0 -21.83% | -7,00 -6,73 -3.96% | -6,78 -7,37 7.95% | -7,88 -8,38 5.88% | -10,7 | -11,2 | -15,8 | -18,2 | -19,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,5 -13,7 23.01% | -16,7 -12,1 -37.91% | -19,8 -15,9 -24.66% | -17,5 -13,6 -28.78% | -9,76 -14,2 31.46% | -12,2 -10,0 -21.71% | -6,90 -6,73 -2.52% | -6,59 -7,37 10.57% | -6,35 -8,30 23.53% | -10,2 | -11,0 | -15,5 | -17,9 | -19,2 |
|
Net income Million USD | Released Forecast Spread | -10,7 -14,0 23.12% | -16,7 -12,2 -36.76% | -19,8 -15,9 -24.7% | -17,5 -13,6 -28.78% | -9,76 -14,2 31.46% | -12,2 -10,0 -21.71% | -6,90 -6,73 -2.56% | -6,59 -7,37 10.57% | -6,35 -8,30 23.53% | -10,2 | -11,0 | -15,5 | -17,9 | -19,2 |
|
EPS USD | Released Forecast Spread | -1,50 -2,18 31.03% | -2,70 -1,73 -56.52% | -3,00 -2,40 -25% | -2,40 -2,00 -20% | -1,50 -2,10 28.57% | -0,84 -1,50 43.78% | -0,94 -0,86 -9.3% | -0,66 -0,68 2.94% | -0,22 -0,30 27.27% | -0,36 | -0,37 | -0,49 | -0,56 | -0,64 |
| Announcement Date | 10/02/22 | 23/06/22 | 11/08/22 | 10/11/22 | 07/02/23 | 28/06/23 | 10/08/23 | 09/11/23 | 13/02/24 | - | - | - | - | - |
More events
Past sector events for Vistagen Therapeutics, Inc.
| Today | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 21:15 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:10 | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:09 | XENCOR, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:02 | SPYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:01 | MACROGENICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:01 | ARROWHEAD PHARMACEUTICALS, INC.: Q2 2024 Earnings Release |
| 09/05/2024 21:00 | ALX ONCOLOGY HOLDINGS INC.: Q1 2024 Earnings Release |
| 09/05/2024 13:00 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release |
| 09/05/2024 12:30 | WAVE LIFE SCIENCES LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VTGN Stock
- Calendar Vistagen Therapeutics, Inc.
